DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
Strategic healthcare investments in medical technology. $100M+ capital affiliation, 100+ years experience. Transforming patient care through innovative solutions.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| JSTAR Horizon Fund II-A, LP | 2026 | Fundraising | $2.6M | n/a | 0 |
| JStar Capital Investments III, LLC | 2025 | Newly closed | $2.8M | n/a | 0 |
| JSTAR HORiZON FUND II LP | 2025 | Fundraising | $22.0M | $32.7M | 0 |
| JStar Capital Investments II, LLC | 2024 | Early deployment | $2.5M | n/a | 0 |
| JStar Capital Investments I, LLC | 2024 | Early deployment | $500,000 | n/a | 0 |
| JStar Capital Investments IV, LLC | 2024 | Early deployment | $25.3M | n/a | 0 |
Also named here, with no published line of their own (reach them through the firm): Evan Pritchard (Senior Managing Director & Co-Founder), Jared Leger (Managing Director & Co-Founder), Kevin Lewis (Director), Dr. Vinh Nguyen (Director), David Nelson (Director), Beau Barnes (CFO), Jessica Jasso (Vice President of Operations), Scott T. Gordon (Portfolio).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan